Patent · US Active

Compositions and methods for enhancing cancer radiotherapy

US11206861B2 · kind B2 · utility

0Cited by
13References
16Claims
0Family size

Inventor

Key dates

Filing dateOct 3, 2017
Grant dateDec 28, 2021
Priority date—
Expiry dateOct 3, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nutritional supplement is described that enhances and provides synergistic effects when used in combination with radiotherapy to treat tumors, both reducing tumor size and preventing metastasis. The nutritional supplement has been also found to be effective in reducing negative side effects of concurrent radiotherapy, including inflammation, weight loss, muscle wasting, neutropenia, and loss of cells from the lining of the gut.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.